GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » IMCD NV (XAMS:IMCD) » Definitions » Debt-to-EBITDA

IMCD NV (XAMS:IMCD) Debt-to-EBITDA : 2.27 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is IMCD NV Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

IMCD NV's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €25 Mil. IMCD NV's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €1,250 Mil. IMCD NV's annualized EBITDA for the quarter that ended in Dec. 2023 was €562 Mil. IMCD NV's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 2.27.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for IMCD NV's Debt-to-EBITDA or its related term are showing as below:

XAMS:IMCD' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.04   Med: 2.31   Max: 3.22
Current: 2.25

During the past 13 years, the highest Debt-to-EBITDA Ratio of IMCD NV was 3.22. The lowest was 1.04. And the median was 2.31.

XAMS:IMCD's Debt-to-EBITDA is ranked better than
50.33% of 1212 companies
in the Chemicals industry
Industry Median: 2.275 vs XAMS:IMCD: 2.25

IMCD NV Debt-to-EBITDA Historical Data

The historical data trend for IMCD NV's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMCD NV Debt-to-EBITDA Chart

IMCD NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.45 1.89 1.04 1.69 2.25

IMCD NV Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.07 1.60 1.82 1.43 2.27

Competitive Comparison of IMCD NV's Debt-to-EBITDA

For the Specialty Chemicals subindustry, IMCD NV's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IMCD NV's Debt-to-EBITDA Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, IMCD NV's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where IMCD NV's Debt-to-EBITDA falls into.



IMCD NV Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

IMCD NV's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(24.743 + 1250.467) / 567.3
=2.25

IMCD NV's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(24.743 + 1250.467) / 561.888
=2.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.


IMCD NV  (XAMS:IMCD) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


IMCD NV Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of IMCD NV's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


IMCD NV (XAMS:IMCD) Business Description

Traded in Other Exchanges
Address
Wilhelminaplein 32, Rotterdam, NLD, 3072 DE
IMCD NV manufactures and sells a variety of chemicals and food ingredients. The firm's product portfolio consists of two categories: Life Science consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care and I&I, and The Industrial segment contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments; EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment.

IMCD NV (XAMS:IMCD) Headlines

No Headlines